Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackfinch Spr. Regulatory News (BFSP)

Share Price Information for Blackfinch Spr. (BFSP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.00
Bid: 92.00
Ask: 96.00
Change: 0.00 (0.00%)
Spread: 4.00 (4.348%)
Open: 94.00
High: 94.00
Low: 94.00
Prev. Close: 94.00
BFSP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of a General Meeting

7 Oct 2022 12:35

RNS Number : 2110C
Blackfinch Spring VCT PLC
07 October 2022
 

Blackfinch Spring VCT plc (the "Company")

 

Results of a General Meeting

 

At a General Meeting of the Company held on Friday 7 October 2022 at 11.00am, the following resolutions were duly passed.

 

Ordinary Resolutions

1. That, the Directors be and hereby are generally and unconditionally authorised in accordance with Section 551 of the CA 2006 to exercise all of the powers of the Company to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal value of £435,000 in connection with the Offer and other offers for subscription, representing approximately 225% of the issued share capital of the Company as at 1 September 2022, being the latest practical date prior to publication of this document, provided that the authority conferred by this Resolution 1 shall expire at the conclusion of the Company's next annual general meeting or on the expiry of fifteen months following the passing of this Resolution 1, whichever is the later (unless previously renewed, varied or revoked by the Company in general meeting).

2. That, the payment by the Company to Blackfinch Investments Limited of the Investment Manager Promoter Fees, such payment being pursuant to the 2022 Offer Agreement, details of which are set out on pages 6 and 7 of the circular issued to the Company's shareholders dated 2 September 2022 (the "Circular"), be approved.  

Special Resolutions

3. That, the Directors be and hereby are empowered pursuant to Section 570(1) of CA 2006 to allot or make offers or agreements to allot equity securities (which expression shall have the meaning ascribed to it in Section 560(1) of CA 2006) for cash pursuant to the authority given in accordance with Section 551 of CA 2006 by Resolution 1 above as if Section 561(1) of CA 2006 did not apply to such allotments, provided that the power provided by this Resolution 3 shall expire at the conclusion of the Company's next annual general meeting or on the expiry of fifteen months following the passing of this Resolution 3, whichever is the later (unless previously renewed, varied or revoked by the Company in general meeting).

4. That, the Company be and is hereby authorised to make one or more market purchases (within the meaning of section 693(4) of the CA 2006) of Ordinary Shares provided that:

4.1 the maximum aggregate number of Ordinary Shares authorised to be purchased is an amount equal to 14.99% of the issued Ordinary Shares immediately following the closing of the Offer;

4.2 the minimum price which may be paid for an Ordinary Share is their nominal value;

4.3 the maximum price which may be paid for an Ordinary Share is an amount equal to the higher of (i) 105% of the average of the middle market quotation per Share taken from the London Stock Exchange daily official list for the five Business Days immediately preceding the day on which such Ordinary Share is to be purchased; and (ii) the amount stipulated by the UK version of Article 5(6) of Market Abuse Regulation (596/2014/EU);

4.4 unless renewed, the authority hereby conferred shall expire either at the conclusion of the annual general meeting of the Company following the passing of this Resolution 4 or on the expiry of fifteen months from the passing of this Resolution 4, whichever is the later, save that the Company may, prior to such expiry, enter into a contract to purchase Ordinary Shares which will or may be completed or executed wholly or partly after such expiry.

5. That, subject to approval by the High Court of Justice, the amount standing to the credit of the share premium account of the Company at the date an order is made confirming such cancellation by the Court be and hereby is cancelled.

 

 

 

 ResolutionFor & DiscretionaryAgainstWithheld
1.To authorise the Directors to allot shares130,435 - 100%0 - 0%3,140
2.To approve the payment of the promoter fees130,435 - 100%0 - 0%3,140
3.To disapply pre-emption rights 127,247 - 97.56%3,188 - 2.44%3,140
4.To authorise the Company to buy back shares130,435 - 100%0 - 0%3,140
5.To cancel the share premium account130,435 - 100%0 - 0%3,140

 

 

For further information please contact:

 

Blackfinch Investments Limited (Investment Manager) - 01452 717070

 

The City Partnership (UK) Limited (Company Secretary) - enquiries@city.uk.com - Robin Smeaton

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMUPGPWUUPPGGM
Date   Source Headline
2nd May 20247:00 amRNSTotal Voting Rights
26th Apr 20242:15 pmRNSAnnual Financial Report
22nd Apr 202410:15 amRNSIssue of Equity - Admission Date
5th Apr 20241:37 pmRNSIssue of Equity
2nd Apr 20244:02 pmRNSTotal Voting Rights
26th Mar 20245:01 pmRNSIssue of Equity
1st Mar 20249:10 amRNSTotal Voting Rights
29th Feb 20241:28 pmRNSIssue of Equity
13th Feb 202411:44 amRNSDividend Declaration
9th Feb 20245:00 pmRNSIssue of Equity
2nd Feb 20244:03 pmRNSPublication of Suppl.Prospcts
25th Jan 202411:53 amRNSNet Asset Value per Share
19th Jan 20244:34 pmRNSIntention to Pay an Interim Dividend
3rd Jan 20245:50 pmRNSIssue of Equity - Admission Date
1st Dec 202311:48 amRNSTotal Voting Rights
30th Nov 20231:41 pmRNSIssue of Equity
1st Nov 20239:37 amRNSNet Asset Value per Ordinary Share
11th Oct 20231:16 pmRNSResult of General Meeting
7th Sep 20234:06 pmRNSPublication of Prospectus and Circular
4th Sep 20239:35 amRNSTotal Voting Rights
30th Aug 20234:57 pmRNSHalf-year Report
30th Aug 20234:42 pmRNSIssue of Equity
7th Aug 202312:38 pmRNSDirectorate Changes
2nd Aug 20233:40 pmRNSTotal Voting Rights
26th Jul 20232:20 pmRNSNet Asset Value(s)
4th Jul 202310:27 amRNSIssue of Equity
8th Jun 20233:01 pmRNSResult of AGM
27th Apr 20234:12 pmRNSNet Asset Value(s)
25th Apr 202312:38 pmRNSIssue of Supplementary.Prospectus
24th Apr 20232:57 pmRNSAnnual Financial Report
5th Apr 20236:15 pmRNSIssue of Equity
29th Mar 20239:28 amRNSIssue of Equity
22nd Mar 20235:14 pmRNSIssue of Equity
14th Mar 202312:54 pmRNSSVB Failure – No Impact on Company’s NAV
1st Mar 20231:46 pmRNSIssue of Equity
3rd Feb 202310:52 amRNSNet Asset Value(s)
31st Jan 20233:40 pmRNSIssue of Equity
2nd Dec 202212:33 pmEQSHardman & Co Research: Blackfinch Spring VCT (BFSP) - Blackfinch Investments Limited
1st Dec 20225:51 pmRNSIssue of Equity
11th Nov 20225:00 pmRNSNet Asset Value(s)
7th Oct 202212:35 pmRNSResults of a General Meeting
2nd Sep 20224:11 pmRNSPublication of Prospectus & Circular
30th Aug 202210:17 amRNSHalf-year Report
22nd Aug 202212:30 pmRNSIssue of Equity
21st Jul 20229:28 amRNSNet Asset Value per Ordinary Share
22nd Jun 20229:28 amRNSIssue of Equity
8th Jun 202211:48 amRNSResult of AGM
18th May 20225:20 pmRNSNet Asset Value per Ordinary Share
18th May 20225:17 pmRNSIssue of a Supplementary Prospectus
21st Apr 202210:51 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.